However, in BPH, there are no data proving the beneficial or non-beneficial effects of PSs through an estrogen-mediated mechanism; the estrogenic effect at the level of prostate tissue depends on the ability of PSs to stimulate ER but also on the ER-α/ER-β ratio. The gene discussed is ESR2; the disease is benign prostatic hyperplasia.